GENFF (Genflow Biosciences) Other Current Payables: $0.02 Mil (As of Dec. 2025)


What is Genflow Biosciences Other Current Payables?

Genflow Biosciences GENFF Other Current Payables is $0.02 Mil as of Dec. 2025. The stock has 1 warning sign investors should review.

Genflow Biosciences's Other Current Payables for the quarter that ended in Dec. 2025 was $0.02 Mil.

Genflow Biosciences's quarterly Other Current Payables increased from Dec. 2024 ($0.02 Mil) to Jun. 2025 ($0.25 Mil) but then declined from Jun. 2025 ($0.25 Mil) to Dec. 2025 ($0.02 Mil).

Genflow Biosciences's annual Other Current Payables declined from Dec. 2023 ($0.04 Mil) to Dec. 2024 ($0.02 Mil) but then increased from Dec. 2024 ($0.02 Mil) to Dec. 2025 ($0.02 Mil).

Genflow Biosciences Other Current Payables Related Terms

Genflow Biosciences Other Current Payables Historical Data

* Premium members only.

The historical data trend for Genflow Biosciences's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genflow Biosciences Other Current Payables Chart

Genflow Biosciences Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Payables
0.02 0.01 0.04 0.02 0.02

Genflow Biosciences Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.04 0.02 0.02 0.25 0.02

Genflow Biosciences Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of $0.02 Mil mean?
Genflow Biosciences (GENFF) has a Other Current Payables of $0.02 Mil as of Dec. 2025. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Genflow Biosciences and its competitors.
Is Genflow Biosciences' Other Current Payables too high?
Genflow Biosciences' current Other Current Payables is $0.02 Mil.
How does Genflow Biosciences' Other Current Payables compare to VRTX and REGN?
Genflow Biosciences' Other Current Payables of $0.02 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Biotechnology company?
A good Other Current Payables depends on the Biotechnology industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Genflow Biosciences and its competitors. Genflow Biosciences's current Other Current Payables is $0.02 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genflow Biosciences stock overvalued right now?
Genflow Biosciences (GENFF) has a current Other Current Payables of $0.02 Mil. The current Other Current Payables is $0.02 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For Genflow Biosciences (GENFF), the current Other Current Payables is $0.02 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Genflow Biosciences Business Description

Other Exchanges GENF:UKWQ5:Germany
Address 6 Heddon Street, London, GBR, W1B 4BT
Genflow Biosciences PLC is a preclinical biotechnology company focused on the development of biological interventions (namely gene therapies) which are aimed at tackling the effects of aging, potentially slowing or halting the aging process and so reducing the incidence of age-related diseases and thereby increasing health span. Its flagship compound, GF-1002, is based on the delivery of a variant of the SIRT6 gene and is currently in preclinical development.